Remove company biofourmis
article thumbnail

Biofourmis quietly parts company with CEO Rajput

pharmaphorum

Biofourmis quietly parts company with CEO Rajput Phil.Taylor Wed, 06/09/2023 - 08:21 Bookmark this

105
105
article thumbnail

STAT+: Unicorn down: Following layoffs, Biofourmis CEO quietly departs

STAT

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.  The Boston-based company was valued at $1.3 The Boston-based company was valued at $1.3 Continue to STAT+ to read the full story…

Hospitals 129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biofourmis reports on the trends and opportunities using digital measures in R&D

Outsourcing Pharma

After visiting Biofourmis in Boston last year, OSP was impressed with the remote care the company could offer people from the comfort of their own homes.

91
article thumbnail

ViVE 2024: GE HealthCare taps Biofourmis to expand its reach into virtual care at-home solutions

Fierce Healthcare

LOS ANGELES—GE HealthCare is tapping virtual care company Biofourmis to extend the reach of patient monitoring tech from hospitals into patients’ homes. Announced at the ViVE 2024 conference on Monday, the collaboration leverages the combined capabilities of both companies to scale and deliver care-at-home solutions, executives said.

article thumbnail

Biofourmis is digital health’s latest unicorn, after raising $300m

pharmaphorum

Biofourmis has raised $300 million in fourth-round financing, sending its value rocketing to around $1.3 ” The new funding round takes the total raised to date by Biofourmis to $445 million, and was led by private equity firm General Atlantic, with support from existing investors including CVS Health. .”

article thumbnail

Digital health firm Biofourmis adds another $20m to its funding pot

pharmaphorum

One of the digital health sector’s latest unicorn companies – Biofourmis – has upscaled its recent fourth round financing, adding $20 million to the $300 million it raised in April. ” The post Digital health firm Biofourmis adds another $20m to its funding pot appeared first on. .

article thumbnail

Investors bet on decentralized trial technology

Outsourcing Pharma

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.

72